A phase I study of the oral platinum agent satraplatin in sequential combination with capecitabine in the treatment of patients with advanced solid malignancies

By Gallerani Elisa   Bauer Jean   Hess Dagmar   Boehm Steffen   Droege Cornelia   Jeckelmann Sandrine   Miani Monica   Herrmann Richard   Marsoni Silvia   Sperka Sabine   Sessa Cristiana  

Acta Oncologica, Vol. 50, Iss. 7, 2011-10 ,pp. : 1105-1110

Informa Healthcare

Access to resources Recommend Favorite

Phase I dosage finding and pharmacokinetic study of intravenous topotecan and oral erlotinib in adults with refractory solid tumors

By Stewart Clinton   Tagen Michael   Schwartzberg Lee   Blakely L.   Tauer Kurt   Smiley Linda  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 561-568

Springer Publishing Company

Access to resources Recommend Favorite

Five days of oral topotecan (hycamtin ( R)), a phase I and pharmacological study in adult patients with solid tumours

By Gerrits C.J.H.   Burris H.   Schellens J.H.M.   Planting A.S.T.   van den Burg M.E.L.   Rodriguez G.I.   van Beurden V.   Loos W.J.   Hudson I.   Fields S.   Verweij J.   von Hoff D.D.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1030-1035

Elsevier

Access to resources Recommend Favorite

Topotecan preceded by oxaliplatin using a 3 week schedule - a phase I study in advanced cancer patients

By Gross-Goupil M.   Lokiec F.   Lopez G.   Tigaud J.-M.   Hasbini A.   Romain D.   Misset J.-L.   Goldwasser F.  

European Journal of Cancer, Vol. 38, Iss. 14, 2002-09 ,pp. : 1888-1898

Elsevier

Access to resources Recommend Favorite

Phase I Study of Alternating Doublets of Topotecan/Carboplatin and Paclitaxel/Carboplatin in Patients with Newly Diagnosed, Advanced Ovarian Cancer

By Gordon A.N.   Hancock K.C.   Matthews C.M.   Messing M.   Stringer C.A.   Doherty M.G.   Teneriello M.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 129-135

Elsevier

Access to resources Recommend Favorite